BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21703456)

  • 1. [Update on psoriasis at the Dermatology Day conference, Paris 2010].
    Battistella M; Boulinguez S
    Ann Dermatol Venereol; 2011 Apr; 138(2 Suppl 2):H1-10. PubMed ID: 21703456
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?
    Thomas JA; Aithal GP
    Am J Clin Dermatol; 2005; 6(6):357-63. PubMed ID: 16343024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine in severe psoriasis. Results of a meta-analysis in 579 patients.
    Faerber L; Braeutigam M; Weidinger G; Mrowietz U; Christophers E; Schulze HJ; Mahrle G; Meffert H; Drechsler S
    Am J Clin Dermatol; 2001; 2(1):41-7. PubMed ID: 11702620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [News on psoriasis from the 2010 Dermatology Days in Paris].
    Boulinguez S
    Ann Dermatol Venereol; 2011 May; 138(5 Suppl 1):H1-5. PubMed ID: 21703458
    [No Abstract]   [Full Text] [Related]  

  • 5. Moderate to severe plaque psoriasis - treatment with drugs of the classic scheme.
    Arnone M; Carvalho AVE; Takahashí MDF; Bernardo WM
    Rev Assoc Med Bras (1992); 2019 May; 65(4):530-534. PubMed ID: 31066805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate-induced liver cirrhosis in a patient of psoriasis.
    Avasthi G; Bhatt P; Singh J
    J Assoc Physicians India; 2012 May; 60():47-8. PubMed ID: 23029724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of cyclosporine versus methotrexate in severe psoriasis: a study from north India.
    Sandhu K; Kaur I; Kumar B; Saraswat A
    J Dermatol; 2003 Jun; 30(6):458-63. PubMed ID: 12810993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current topics in psoriasis].
    Boulinguez S
    Ann Dermatol Venereol; 2011 Jun; 138(6 Suppl 1):H1-5. PubMed ID: 21703467
    [No Abstract]   [Full Text] [Related]  

  • 9. Folate with methotrexate: big benefit, questionable cost.
    Brownell I; Strober BE
    Br J Dermatol; 2007 Jul; 157(1):213. PubMed ID: 17578449
    [No Abstract]   [Full Text] [Related]  

  • 10. Methotrexate in psoriasis: consensus conference.
    Roenigk HH; Auerbach R; Maibach H; Weinstein G; Lebwohl M
    J Am Acad Dermatol; 1998 Mar; 38(3):478-85. PubMed ID: 9520032
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy, safety and drug survival of conventional agents in pediatric psoriasis: A multicenter, cohort study.
    Ergun T; Seckin Gencosmanoglu D; Alpsoy E; Bulbul-Baskan E; Saricam MH; Salman A; Onsun N; Sarioz A
    J Dermatol; 2017 Jun; 44(6):630-634. PubMed ID: 27943425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate hepatotoxicity: what is the evidence?
    Ahern MJ; Smith MD; Roberts-Thomson PJ
    Inflamm Res; 1998 Apr; 47(4):148-51. PubMed ID: 9628257
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methotrexate in psoriasis: do we need to give a test dose?].
    Carretero-Hernández G
    Actas Dermosifiliogr; 2012; 103(1):1-4. PubMed ID: 22093543
    [No Abstract]   [Full Text] [Related]  

  • 14. Generalized pustular psoriasis developing during withdrawal of short-term cyclosporin therapy.
    Georgala S; Koumantaki E; Rallis E; Papadavid E
    Br J Dermatol; 2000 May; 142(5):1057-8. PubMed ID: 10809879
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis.
    Bigby M
    Arch Dermatol; 2004 Mar; 140(3):347-8. PubMed ID: 15023778
    [No Abstract]   [Full Text] [Related]  

  • 16. Methotrexate use and liver disease--a causal relationship?
    Schmitt J; Singh JA
    Br J Dermatol; 2014 Jul; 171(1):6-7. PubMed ID: 25066285
    [No Abstract]   [Full Text] [Related]  

  • 17. The objective Psoriasis Area and Severity Index: a randomized controlled pilot study comparing the effectiveness of ciclosporin and methotrexate.
    Choi CW; Kim BR; Seo E; Youn SW
    Br J Dermatol; 2017 Dec; 177(6):1740-1741. PubMed ID: 28129675
    [No Abstract]   [Full Text] [Related]  

  • 18. The quest for an evidence-based approach to surveillance for methotrexate-related hepatotoxicity: promise and perils.
    Dawwas MF; Aithal GP
    Br J Dermatol; 2015 Jun; 172(6):1684-1685. PubMed ID: 25523838
    [No Abstract]   [Full Text] [Related]  

  • 19. [Methotrexate in psoriasis: are routine biopsies necessary?].
    Guillaume JC
    Ann Dermatol Venereol; 2006; 133(6-7):513-7. PubMed ID: 16885837
    [No Abstract]   [Full Text] [Related]  

  • 20. Psoriasis, transient elastography and methotrexate: monitoring at a tertiary hospital.
    Koch K
    Australas J Dermatol; 2021 Feb; 62(1):69-70. PubMed ID: 32700316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.